Advertisement

Topics

Takeda Pharmaceuticals North America, Inc. Company Profile

22:11 EDT 25th September 2017 | BioPortfolio

Takeda Pharmaceuticals North America, Inc. is a new kind of pharmaceutical company. We are dedicated to serving patients by providing innovative products that improve their lives with better healthcare. With a foundation built on the tremendous success of ACTOS® (pioglitazone HCl) as well as a robust, early-stage pipeline, TPNA is poised to realize its vision of becoming a world class pharmaceutical company. Our unique culture sets us apart. At TPNA, we are committed to patients, our employees and the community. We have an innovative, entrepreneurial spirit combined with the rich history of our 220-year-old parent company.
Headquartered in Lincolnshire, Illinois, a northern suburb of Chicago, TPNA is a wholly owned U.S. subsidiary of Takeda Pharmaceutical Company Limited, Japan’s largest pharmaceutical company. With more than five years of service in the U.S., we have grown rapidly and each step of that growth remains true to the company’s integrity, heritage and people.

Location

475 Half Day Road
Lincolnshire
Illinois
60069
United States of America

Contact

Phone: 847-383-3000
Email: pr@tpna.com


News Articles [8873 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Laboratory Assistant at Takeda Pharmaceuticals

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Laboratory Assistant at Takeda Pharmaceuticals .MA-Cambridge, Laboratory Assi...

Takeda, Cardurion Pharmaceuticals partner on cardiovascular development

Takeda Pharmaceutical and Cardurion Pharmaceuticals announced the creation of a new cardiovascular development partnership. Cardurion, a recently launched Boston-area based biotechnology company, is f...

Pharmaceuticals in North America [Report Updated: 30062017] Prices from USD $350

Pharmaceuticals in North AmericaSummaryPharmaceuticals in North America industry profile provides topline qualitative and quantitative summary information including: market share, market size value 20...

Takeda and Abingworth invest $100mm in GammaDelta Therapeutics; Takeda has option to buy

Takeda Pharmaceutical Co. Ltd., through its Millennium Pharmaceuticals/Takeda Oncology unit, and Abingworth agreed to together commit up to $100mm in funding to Abingworth-seeded biotech GammaDelta Th...

Nektar and Takeda enter into trial collaboration for myeloma, lymphoma, and colorectal cancer

Nektar Therapeutics and Takeda Pharmaceutical Co. Ltd., through its Takeda Oncology/Millennium Pharmaceuticals division, entered into a trial collaboration to explore the combination of Nektar’s NKT...

Takeda Launches New Subsidiary in Peru

ZURICH, August 22, 2013 /PRNewswire/ -- Demonstrates Takeda's long-term commitment to the Latin American market Takeda Pharmaceuticals International GmbH ("Takeda") today announced further expansion...

North America Continuous Glucose Monitoring System Market Forecast 20152023 [Updated: 01022017] Prices from USD $1

LIST OF TABLESTABLE 1 NORTH AMERICA CGMS MARKET BY GEOGRAPHY, 20152023 $MILLIONTABLE 2 NORTH AMERICA CGMS MARKET, BY DEVICE TYPE, 20152023 $MILLIONTABLE 3 NORTH AMERICA SENSORS MARKET, 20152023 $MILLI...

Hikma and Takeda sign new licensing agreement to expand product portfolio in MENA

Hikma Pharmaceuticals has reached an agreement with Takeda Pharmaceutical Company to expand their licensing and distribution agreement to add new products to its existing portfolio in the Middle East ...

Drugs and Medications [572 Associated Drugs and Medications listed on BioPortfolio]

Prevacid [Novartis Consumer Health, Inc.]

PREVACID 24 HRLansoprazole delayed-release capsules 15mg / acid reducer

Tork premium [SCA Tissue North America]

TORK® Soap Foam Antibacterial

Tork premium hand sanitizer foam [SCA Tissue North America]

TORK Hand Sanitizer Foam

Tork premium hand sanitizer foam alcohol-free [SCA Tissue North America]

TORK® Hand Sanitizer Foam Alcohol-Free

Pro therapy md [Valeant Pharmaceuticals North America LLC]

PRO+ THERAPY MD™ ADVANCED ULTRA LIGHT DAY REPAIR SPF 30

PubMed Articles [1610 Associated PubMed Articles listed on BioPortfolio]

Historical and future trends in global source-receptor relationships of mercury.

Growing concern about the risk associated with increasing environmental mercury (Hg) concentrations has resulted in a focus on the relationships between intercontinental emitted and accumulated Hg. We...

Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.

Few studies in North America have quantified the risks of second malignant neoplasms (SMNs) among survivors of childhood non-central nervous system (non-CNS) embryonal tumours due to their rarity. We ...

Transoral thyroidectomy and parathyroidectomy - A North American series of robotic and endoscopic transoral approaches to the central neck.

Most thyroid surgery in North America is completed via a cervical incision, which leaves a permanent scar. Approaches without cutaneous incisions offer aesthetic advantages. This series represents the...

North American matsutake: names clarified and a new species described.

Tricholoma matsutake, known widely as "matsutake," has great commercial and cultural significance in Japan. Because Japanese production is insufficient to meet the high domestic demand, morphologicall...

Arthropod Envenomation in North America.

Arthropods (phylum Arthopoda) account for a higher percentage of morbidity and mortality to humans than do mammalian bites, snake bites, or marine envenomation. They are ubiquitous in domestic dwellin...

Clinical Trials [664 Associated Clinical Trials listed on BioPortfolio]

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceut...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Sorafenib-RT in Treating Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The incidence is highest in Asia and it is increasing in North America, with a two to three fold increase in mor...

Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

The purpose of this study is to assess the bioavailability of dexlansoprazole from a 30 milligram (mg) or 60 mg delayed-release capsule manufactured at Takeda GmbH Plant Oranienburg, Germa...

Companies [3092 Associated Companies listed on BioPortfolio]

Mended Hearts and Takeda Pharmaceuticals North America, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharma...

Takeda Pharmaceutical North America, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharma...

Takeda Pharmaceuticals North America, Inc

Takeda Pharmaceuticals North America, Inc. is a new kind of pharmaceutical company. We are dedicated to serving patients by providing innovative products that improve their lives with better healthcar...

Takeda Pharmaceuticals International, Inc.

Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the larges...

Takeda Pharmaceuticals North America

Takeda Pharmaceuticals North America, Inc. is a new kind of pharmaceutical company. We are dedicated to serving patients by providing innovative products that improve their lives with better healthcar...

More Information about "Takeda Pharmaceuticals North America, Inc." on BioPortfolio

We have published hundreds of Takeda Pharmaceuticals North America, Inc. news stories on BioPortfolio along with dozens of Takeda Pharmaceuticals North America, Inc. Clinical Trials and PubMed Articles about Takeda Pharmaceuticals North America, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Takeda Pharmaceuticals North America, Inc. Companies in our database. You can also find out about relevant Takeda Pharmaceuticals North America, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record